Lessons Learned from Early Closure of a Clinical Trial for Steroid-refractory Acute GVHD
2022 02
Journal Article
Authors:
Meyers, G.;
Hamadani, M.;
Martens, M.;
Ali, H.;
Choe, H.;
Dawson, P.;
Harris, A.C.;
van Hooren, E.;
Klaassen, W.;
Leifer, E.;
MacMillan, M.L.;
van Oosterhout, Y.;
Perez, L.;
Pusic, I.;
Vo, P.;
Levine, J.E.
Secondary:
Bone Marrow Transplant
Volume:
57
Pagination:
302-303
Issue:
2
PMID:
34815518
URL:
https://pubmed.ncbi.nlm.nih.gov/34815518/
DOI:
10.1038/s41409-021-01529-x
Keywords:
Acute Disease; Clinical Trials as Topic; Drug Resistance; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Steroids
